133 related articles for article (PubMed ID: 16875551)
1. [Natural killer-like T-cell lymphoma/leukemia--a case report and literature review].
Zhang FK; Wang HJ; Wu YH; Dong SX; Li HQ; Yang DL; Chen HS; Chu YL
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):226-30. PubMed ID: 16875551
[TBL] [Abstract][Full Text] [Related]
2. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
[TBL] [Abstract][Full Text] [Related]
3. Immunoprofiling of cell lines derived from natural killer-cell and natural killer-like T-cell leukemia-lymphoma.
Matsuo Y; Drexler HG
Leuk Res; 2003 Oct; 27(10):935-45. PubMed ID: 12860014
[TBL] [Abstract][Full Text] [Related]
4. Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers.
Passetto Falcão R; Pinto Simões B; Garcia AB; Fonseca BA; Terra Filho J
Acta Haematol; 2000; 104(2-3):110-4. PubMed ID: 11154985
[TBL] [Abstract][Full Text] [Related]
5. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity.
Sun T; Brody J; Susin M; Marino J; Teichberg S; Koduru P; Hall WW; Urmacher C; Hajdu SI
Am J Surg Pathol; 1993 Dec; 17(12):1289-99. PubMed ID: 8238737
[TBL] [Abstract][Full Text] [Related]
6. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
7. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course.
Mraz-Gernhard S; Natkunam Y; Hoppe RT; LeBoit P; Kohler S; Kim YH
J Clin Oncol; 2001 Apr; 19(8):2179-88. PubMed ID: 11304770
[TBL] [Abstract][Full Text] [Related]
8. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
9. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
[TBL] [Abstract][Full Text] [Related]
10. [NK-cell lymphomas and NK-like T-cell lymphomas].
Oshimi K
Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
[TBL] [Abstract][Full Text] [Related]
11. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
12. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma.
Drexler HG; Matsuo Y
Leukemia; 2000 May; 14(5):777-82. PubMed ID: 10803505
[TBL] [Abstract][Full Text] [Related]
13. Intracranial nasal natural killer/T-cell lymphoma: immunopathologically-confirmed case and review of literature.
Luther N; Greenfield JP; Chadburn A; Schwartz TH
J Neurooncol; 2005 Nov; 75(2):185-8. PubMed ID: 16283442
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous CD4+ CD56+ hematologic malignancies.
Magro CM; Porcu P; Schaefer J; Erter JW; Furman RR; Shitabata PK; Crowson AN
J Am Acad Dermatol; 2010 Aug; 63(2):292-308. PubMed ID: 20541283
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two cases.
Kagami Y; Sobue R; Ito N; Yatabe Y; Taji H; Suzuki R; Seto M; Ogura M; Suchi T; Morishima Y; Nakamura S
Int J Hematol; 1999 Aug; 70(2):105-11. PubMed ID: 10497849
[TBL] [Abstract][Full Text] [Related]
16. Natural killer-like T-cell lymphoma in a calf.
Nozaki S; Sasaki K; Ando M; Kadota K
J Comp Pathol; 2006 Jul; 135(1):47-51. PubMed ID: 16814804
[TBL] [Abstract][Full Text] [Related]
17. Aggressive primary natural killer cell lymphoma of the caecum: a case report and literature review.
Lei KI; Chow JH; Johnson PJ
Clin Oncol (R Coll Radiol); 1997; 9(3):191-4. PubMed ID: 9269556
[TBL] [Abstract][Full Text] [Related]
18. Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology.
Chott A; Haedicke W; Mosberger I; Födinger M; Winkler K; Mannhalter C; Müller-Hermelink HK
Am J Pathol; 1998 Nov; 153(5):1483-90. PubMed ID: 9811340
[TBL] [Abstract][Full Text] [Related]
19. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
[TBL] [Abstract][Full Text] [Related]
20. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
Liu XY; Atkins RC; Feusner JH; Rowland JM
Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]